A Case with Anti TNF- α Induced Bullous Pemhigoid
Main Article Content
Abstract
Tumor necrosis factor-alpha (TNF-α) plays a crucial role in the development of autoimmune diseases, and anti-TNF-α agents are used in the treatment of this group of diseases. However, some adverse events such as various autoimmune diseases can occur with use of these agents. In this report, we present a female case who was diagnosed as bullous pemphigoid while receiving adalimumab for rheumatoid arthritis. (Turk J Rheumatol 2010; 25: 214-6)
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.